[
  {
    "objectID": "Patrick-Cherry-cv.html",
    "href": "Patrick-Cherry-cv.html",
    "title": "CV of Patrick Cherry, PhD",
    "section": "",
    "text": "Download resume version as pdf"
  },
  {
    "objectID": "Patrick-Cherry-cv.html#contact",
    "href": "Patrick-Cherry-cv.html#contact",
    "title": "CV of Patrick Cherry, PhD",
    "section": "Contact",
    "text": "Contact\n\n patrick [at] pcherry dot io\n upon request\n Senior Scientist | Oncology\n BillionToOne\n San Francisco, California\n pcherry.io\n github.com/pdcherry\n linkedin.com/in/p-cherry\n United States Citizen\n\n\nLast updated on 2025-11-15.\nData-driven résumé made in R using Quarto."
  },
  {
    "objectID": "Patrick-Cherry-cv.html#industry-experience",
    "href": "Patrick-Cherry-cv.html#industry-experience",
    "title": "CV of Patrick Cherry, PhD",
    "section": " Industry Experience",
    "text": "Industry Experience\n\n\nI currently split my time between computational, wet-lab, and management activities. I have worked in a variety of roles ranging from HTP strain onboarding to genomics scientist. I like collaborative environments where I can learn from my peers and–in turn–teach others.\n\nSenior Scientist, Oncology\nBillionToOne, Inc.\nMenlo Park, California\nCurrent - Sep 2024\n\nImplemented department-wide copy number database using extract-transform-load (ETL) procedure on production data\nIdeated, coded, and validated patented method for tumor fraction estimation from plasma aneuploidy data using Gaussian mixture models, custom model selection metric, and custom consensus logic\nSolved DNA variant detection sensitivity issue by designing and implementing a multiplexed amplicon NGS assay with public data sets and internal database of variant data\nProductionized RNA-seq by writing a custom Nextflow pipeline for analysis and automated quality control reporting.\nAnswered business and product design questions from leadership about un-met customer need with internal reports on Notion written in reproducible coding notebooks using Python and R in a HIPAA-manner environment\nAs hiring manager, recruited and hired four Research Associates; managed the Statistics interview\n\n\n\nSenior Scientist, Genomics\nTwist Bioscience, Inc.\nSouth San Francisco, California\nApr 2024 - Dec 2021\n\nInvented and introduced multiple new products to market, yielding $1M+ in new revenue as Tech Lead, including: Pan-cancer cfDNA (v1 & v2) (patented), CNV Controls, RNA Fusion Controls, RNA-seq, and patented adapter removal\nAnswered feasibility questions with Design of Experiment principles and data analysis using R and Python.\nWrote, documented, and maintained production QC pipelines for sub-components and finished good QC; trained end-users in Manufacturing and Quality on their use, interpretation, and reporting.\nMaintained production code (git version control with code review and team best practices) with CD (Github actions); operated in AWS & Databricks high-performance compute environment using Unix shell\nAnswered manufacturing & business questions using SQL / Snowflake database of production events and customer data\n\n\n\nScientist I, Next Generation Sequencing (NGS)\nZymergen, Inc.\nEmeryville, California\nJan 2021 - Apr 2019\n\nBoosted pan-project NGS genotyping success by 45% using Design of Experiment and Estimated Marginal Means modeling for causal inference; Guided demanding and diverse internal customers on complex NGS experiments\nBuilt and disseminated reproducible statistical templates in Rmarkdown and JMP for self-serve NGS data exploration\nRendered strain build and plasmid build reports from LIMS SQL database in MariaDB and R / ggplot2\nDesigned, built, and demonstrated a patented counterselectable marker for the non-model microbe Bacillus subtlis"
  },
  {
    "objectID": "Patrick-Cherry-cv.html#education",
    "href": "Patrick-Cherry-cv.html#education",
    "title": "CV of Patrick Cherry, PhD",
    "section": " Education",
    "text": "Education\n\nPhD in Molecular Biology\nUniversity of Colorado School of Medicine\nAurora/Denver, Colorado\nApr 2019 - Aug 2013\n\nPh.D. in Molecular Biology. Advisor: Jay Hesselberth, PhD. Key courses: 6606 Statistics; 7621 Genome Analysis Workshop.\nThesis: RNA terminus chemistry potentiates decay events targeting HAC1 mRNA during the Unfolded Protein Response\n\n\n\nBA in Molecular Biology with Distinction, minor in Mathematics\nHendrix College\nConway, Arkansas\nMay 2013 - Aug 2009\n\nSenior Capstone Project showing changes of key stress response gene expression to oxidative stress in liver cells\nKey courses: Probability & Statistics; Discrete Mathematics; Adv Biological Chemistry, Analytical Chemistry"
  },
  {
    "objectID": "Patrick-Cherry-cv.html#research-experience",
    "href": "Patrick-Cherry-cv.html#research-experience",
    "title": "CV of Patrick Cherry, PhD",
    "section": " Research Experience",
    "text": "Research Experience\n\n\nI worked on a few projects during my PhD, and the RNA repair project led me to custom 5′-OH RNA-seq libraries, which inspired my fascination with transcriptomics and bioinformatics.\n\nUndergraduate Research Assistant\nLab of Dr. Andres Caro, Hendrix College\nConway, Arkansas\nJan 2013 - Jan 2012\n\n\nSummer Undergraduate Research Fellowship\nLab of Dr. Michael Shiloh, UT Southwestern Medical Center\nDallas, Texas\nJan 2012 - Jan 2012\n\n\nResearch Assistant\nLab of Dr. Joy Sturtevant, Louisiana Health Sciences Center\nNew Orleans, Louisiana\nJan 2011 - Jan 2010"
  },
  {
    "objectID": "Patrick-Cherry-cv.html#intellectual-property",
    "href": "Patrick-Cherry-cv.html#intellectual-property",
    "title": "CV of Patrick Cherry, PhD",
    "section": " Intellectual Property",
    "text": "Intellectual Property\n\n\nWorking at BillionToOne, Twist, and Zymergen on new product research requires confidentiality, but public evidence of accomplishments often comes in patent applications. The Legal teams know me well for being a helpful expert in the process.\n\nLiquid biopsy assay for genomic profiling of circulating tumor DNA\nBillionToOne, Inc.\nMenlo Park, California\nJan 2025\n\nUS Patent Application 19/033,133\nInvention of tumor fraction estimation / in-tissue copy number estimation from aneuploidy signal in plasma\n\n\n\nMethylation-mediated adapter removal on nucleic acid sequences\nTwist Bioscience\nSouth San Francisco, California\nMar 2023\n\nWorldwide Patent WO2023172520A2\nUS 63-317,466\n\n\n\nExpansion of cfDNA for Libraries\nTwist Bioscience\nSouth San Francisco, California\nNov 2021\n\nUS Prov. Pat. Ref No 823.102\n\n\n\nLibraries for mutational analysis\nTwist Bioscience\nSouth San Francisco, California\nApr 2021\n\nWorldwide Patent WO2024073708A1\nConfiguration and fabrication of synthetic DNA & RNA reference standards and synthetic variant sequences\n\n\n\nMethod for counterselection in microorganisms\nZymergen, Inc.\nEmeryville, California\nMar 2021\n\nWorldwide Patent WO2021061694A1 / US 2021_0087586 A1\nDemonstration of novel counterselection mechanism in non-model Bacillus microbe for genetic modification"
  },
  {
    "objectID": "Patrick-Cherry-cv.html#publications",
    "href": "Patrick-Cherry-cv.html#publications",
    "title": "CV of Patrick Cherry, PhD",
    "section": " Publications",
    "text": "Publications\n\n\nI communicate my results clearly, both in writing and in live presentations. I enjoy writing research papers, but my career has required more tech notes and app notes recently.\n\nTwist cfDNA Pan-Cancer Reference Standard v2 Technical Guidance\nTwist Bioscience Product Sheet & FAQ\nSouth San Francisco, California\nJan 2024\n\nPatrick Cherry, Lydia Bonar, & Mike Bocek\n\n\n\nCharacteristics and specificity of the wild-type / 0% VAF reference material\nTwist Bioscience\nSouth San Francisco, California\nApr 2022\n\nPatrick Cherry & Mike Bocek\n\n\n\nTwist Pan-cancer synthetic reference materials technical guide (deprecated)\nTwist Bioscience\nSouth San Francisco, California\nDec 2021\n\nPatrick Cherry & Mike Bocek\n\n\n\nMultiple decay events target HAC1 mRNA during splicing to regulate the unfolded protein response\neLife\nAurora/Denver, Colorado\nMar 2019\n\nCherry, P., Peach, S., & Hesselberth, J.\n\n\n\nGenetic bypass of essential RNA repair enzymes in budding yeast\nRNA\nAurora/Denver, Colorado\nDec 2017\n\nCherry, P., White, L., York, K., & Hesselberth, J."
  },
  {
    "objectID": "Patrick-Cherry-cv.html#presentations-talks",
    "href": "Patrick-Cherry-cv.html#presentations-talks",
    "title": "CV of Patrick Cherry, PhD",
    "section": " Presentations & Talks",
    "text": "Presentations & Talks\n\n\nI give audience-centered presentations by adapting on the fly and over time to the venue and occasion. I like to transfer knowledge by giving methods/best practices talks whose slides can also serve as documentation.\n\nTumor fraction estimation and tissue copy number inference using copy number signal from liquid biopsy\nAmerican Association for Cancer Researchers\nChicago, Illinois\nApr 2025\n\nPatrick Cherry, Wen Zhou, David Tsao\n\n\n\nTwist pan-cancer reference standard V2: Enhanced precision and reduced errors in ctDNA analysis\nAdvances in Genome Biology and Technology, Twist Bioscience\nOrlando, Florida\nFeb 2024\n\nLydia Bonar, Patrick Cherry, Michael Bocek, Shawn Gorda, Derek Murphy, and Esteban Toro\n\n\n\nHigh sensitivity detection of specific ultra low-frequency somatic mutations for minimal residual disease (MRD) monitoring\nInternational Society of Liquid Biopsy Annual Congress, Twist Bioscience\nMadrid, Spain\nNov 2023\n\nTina Han, Tong Liu, Michael Bocek, Patrick Cherry, Shawn Gorda, Nairi Pezeshkian, Dan Nasko, Po-Yuan Tung, Derek Murphy, Esteban Toro\n\n\n\nHigh sensitivity detection of specific ultra low-frequency somatic mutations for minimal residual disease (MRD) monitoring\nAmerican Association for Cancer Researchers, Twist Bioscience\nOrlando, Florida\nApr 2023\n\nTong Liu, Michael Bocek, Patrick Cherry, Shawn Gorda, Jean Challacombe, Derek Murphy, Esteban Toro\n\n\n\nAn end-to-end workflow for accurate methylation detection\nAmerican Association for Cancer Researchers, Twist Bioscience\nOrlando, Florida\nApr 2023\n\nLydia Bonar, Kristin Butcher, Michael Bocek, Holly Corbitt, Bryan Hoglund, Cibelle Nassif, Patrick Cherry, Derek Murphy, Jean Challacombe, Esteban Toro\n\n\n\nTwist pan-cancer synthetic RNA fusion control for assay development\nAmerican Association for Cancer Researchers, Twist Bioscience\nOrlando, Florida\nApr 2023\n\nPatrick Cherry, Jason Corwin, Yu Cai, Kit Fuhrman, Jean Challacombe, Derek Murphy, Esteban Toro\n\n\n\nColorado RNA Club Industry Session\nColorado RNA Club\nBoulder, Colorado\nApr 2023\n\n\nUse of synthetic CNV fragments to mimic copy number alterations for ctDNA reference standards\nAdvances in Genome Biology and Technology, Twist Bioscience\nHollywood, Florida\nFeb 2023\n\nJason Corwin, Patrick Cherry, Shawn Gorda, Michael Bocek, Jean Challacombe, Derek Murphy, Esteban Toro\n\n\n\nMethylation Controls to detect for methylation level quantification in the Twist Targeted Methylation Sequencing workflow\nAdvances in Genome Biology and Technology\nHollywood, Florida\nFeb 2023\n\nKristin Butcher, Michael Bocek, Patrick Cherry, Jean Challacombe, Esteban Toro\n\n\n\nEfficient, high sensitivity detection of oncogenic variants with UMIs and target enrichment\nEuropean Human Genetics Conference\nVienna, Austria\nMay 2022\n\nMichael Bocek, Lydia Bonar, Jean Challacombe, Richard Gantt, Patrick Cherry, Rebecca Liao, Derek Murphy, Esteban Toro\n\n\n\nTwist pan-cancer synthetic reference materials for cell-free DNA (cfDNA) assay development\nAmerican Association for Cancer Researchers, Twist Bioscience\nNew Orleans, Louisiana\nApr 2022\n\nPatrick Cherry, Alonzo Lee, Michael Bocek, Jinfeng Shen, Derek Murphy, Esteban Toro\n\n\n\nPan-cancer Reference Standard: Methods in Automation & Future Needs\nTwist Automation Group Meeting\nSouth San Francisco, CA\nApr 2022\n\n\nTwist reference material products: current methods and future applications\nTwist R&D Symposium\nSouth San Francisco, CA\nMar 2022\n\n\nPan-cancer Reference Standard: Methods & Lessons from NPI & QC\nTwist R&D Meeting\nSouth San Francisco, CA\nFeb 2022\n\n\nMolecular Methods Meet the Standards: Or how I learned to stop worrying and love UV-quantification\nTwist R&D Meeting\nSouth San Francisco, CA\nJul 2021\n\n\nColorado RNA Club Industry Session\nColorado RNA Club\nBoulder, Colorado\nApr 2021\n\n\nR use at Zymergen\nZ-Tech Talk\nEmeryville, CA\nJun 2020\n\n\nData-driven troubleshooting of NGS experiments\nData Science Talk\nEmeryville, CA\nApr 2020\n\n\nNGS Sample Preparation Deep-Dive\nNGS Technical Talk Series\nEmeryville, CA\nMar 2020\n\n\nRNA terminus chemistry potentiates decay events that target HAC1 mRNA during the unfolded protein response\nThesis Defense Seminar\nAurora, Colorado\nJan 2019\n\n\nRNA modification and decay regulates the unfolded protein response\nRocky Mountain Yeast Meeting Poster\nFort Collins, Colorado\nJan 2019\n\n\nWhat the unfolded protein response teaches us about RNA decay\nBolie Scholar Talk, Molecular Biology Program Retreat\nWinter Park, CO\nOct 2018\n\n\nGenetic bypass of essential yeast RNA repair enzymes\nRocky Mountain Yeast Meeting Poster\nGolden, Colorado\nJan 2018\n\n\nGenetic bypass of essential yeast RNA repair enzymes\nMolecular Biology Program Update Talk\nAurora, Colorado\nOct 2017\n\n\nRNA processing regulates the unfolded protein response\nCSHL: mRNA Processing Meeting Talk\nCold Spring Harbor, New York\nAug 2017\n\n\nGenetic bypass of essential yeast RNA repair enzymes\nRocky Mountain Yeast Meeting Poster\nBoulder, Colorado\nJan 2017\n\n\nRNA processing regulates the unfolded protein response\nRNA Club Talk\nBoulder, Colorado\nDec 2016\n\n\nRNA Healing and Destruction\nMolecular Biology Program Update Talk\nAurora, Colorado\nOct 2016\n\n\nRNA processing regulates the unfolded protein response\nRocky Mountain Yeast Meeting Poster\nFort Collins, Colorado\nJan 2016\n\n\nTurnover of endonucleolytic products of No-Go mRNA decay\nRNA Stability Meeting\nEstes Park, Colorado\nJun 2015\n\n\nRNA 5′-kinase-mediated co-translational mRNA decay\nMolecular Biology Program Update Talk\nAurora, Colorado\nFeb 2015\n\n\nRNA 5′-kinase-mediated co-translational mRNA decay\nRocky Mountain Yeast Meeting Poster\nAurora, Colorado\nJan 2015\n\n\nRNA 5′-kinase-mediated co-translational mRNA decay\nRocky Mountain Yeast Meeting Poster\nBoulder, Colorado\nJan 2014\n\n\nCoordinated upregulation of antioxidant protection and mitochondrial DNA biosynthesis in liver cells by oxidative stress\nSenior Undergraduate Capstone Research Talk\nConway, Arkansas\nJan 2013"
  },
  {
    "objectID": "Patrick-Cherry-cv.html#trainees-direct-reports",
    "href": "Patrick-Cherry-cv.html#trainees-direct-reports",
    "title": "CV of Patrick Cherry, PhD",
    "section": " Trainees & Direct Reports",
    "text": "Trainees & Direct Reports\n\n\nWhile I’ve not held a role with “manager” in the title, all Scientist positions I’ve held have involved formal report management responsibility. I take managing and mentoring seriously; I emphasize trust, learning, and growth with my reports.\n\nLaura Herron, MS, University of California San Diego, Research Associate\nBillionToOne, Inc.\nMenlo Park, California\nCurrent - Jan 2025\n\n\nDerek Cai, BS, University of California San Diego, Research Associate I\nTwist Bioscience\nSouth San Francisco, California\nJan 2024 - Jan 2022\n\n\nLydia Bonar, MS, Johns Hopkins University, Scientist\nTwist Bioscience\nSouth San Francisco, California\nJan 2024 - Jan 2021\n\n\nAlonzo Lee, BS, University of California Santa Cruz, Scientist\nTwist Bioscience\nSouth San Francisco, California\nJan 2022 - Jan 2021\n\n\nKaisle Hill, BA, University of California Berkeley, Senior Research Associate\nZymergen, Inc.\nEmeryville, California\nJan 2021 - Jan 2020\n\n\nRachel A Jones, MS, University of Arizona, Postdoctoral Fellow\nUniversity of Colorado School of Medicine\nAurora/Denver, Colorado\nJan 2017\n\n\nLaura K White, MS, Biotechnology, Johns Hopkins University, Postdoctoral Fellow\nUniversity of Colorado School of Medicine\nAurora/Denver, Colorado\nJan 2016\n\n\nHaven Himmighoefer, Undergraduate, University of Colorado Denver\nUniversity of Colorado School of Medicine\nAurora/Denver, Colorado\nJan 2016 - Jan 2014\n\n\nLeslie Aranda, Undergraduate, University of California Riverside\nUniversity of Colorado School of Medicine\nAurora/Denver, Colorado\nJan 2015"
  },
  {
    "objectID": "posts/2024_10_08-SF_political_support_clustering.html",
    "href": "posts/2024_10_08-SF_political_support_clustering.html",
    "title": "San Francisco political support clustering",
    "section": "",
    "text": "CitationBibTeX citation:@online{cherry2024,\n  author = {Cherry, Patrick},\n  title = {San {Francisco} Political Support Clustering},\n  date = {2024-10-08},\n  url = {https://pdcherry.github.io/posts/2024_10_08-SF_political_support_clustering.html},\n  langid = {en}\n}\nFor attribution, please cite this work as:\nCherry, Patrick. 2024. “San Francisco Political Support\nClustering.” October 8, 2024. https://pdcherry.github.io/posts/2024_10_08-SF_political_support_clustering.html."
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Frameshift",
    "section": "",
    "text": "Order By\n       Default\n         \n          Title\n        \n         \n          Date - Oldest\n        \n         \n          Date - Newest\n        \n         \n          Author\n        \n     \n  \n    \n      \n      \n    \n\n\n\n\n\n\n\n\n\n\nHow my partner & I do ‘calendaring’\n\n\n\n\n\n\ntime management\n\n\ncalendar\n\n\nrelationships\n\n\n\nMisadventures in calendar sharing led me along a systematic test of top calenar providers and showed that standards mean nothing\n\n\n\n\n\nSep 3, 2025\n\n\nPatrick Cherry\n\n\n\n\n\n\n\n\n\n\n\n\nSan Francisco political support clustering\n\n\n\n\n\n\npolitics\n\n\n\nClustering analysis on the ballot measure and political race recommendations by the various political organizations in San Francisco \n\n\n\n\n\nOct 8, 2024\n\n\nPatrick Cherry\n\n\n\n\n\n\n\n\n\n\n\n\nSan Francisco’s November 2024 ballot review\n\n\n\n\n\n\npolitics\n\n\nopinions\n\n\n\nSan Francisco has a big ballot incoming to voters this November, with 25 total ballot measures for voters to decide upon before election day.\n\n\n\n\n\nAug 29, 2024\n\n\nPatrick Cherry\n\n\n\n\n\n\n\n\n\n\n\n\nCopy-number-variant (CNV) TE Panel Analysis\n\n\n\n\n\n\ndata\n\n\ncode\n\n\ntarget enrichment\n\n\nCNV\n\n\nnext generation sequencing\n\n\ngenetics\n\n\ngenomics\n\n\n\n\n\n\n\n\n\nJul 15, 2024\n\n\nPatrick Cherry\n\n\n\n\n\n\n\n\n\n\n\n\nCITE-seq analysis proof-of-concept\n\n\n\n\n\n\nmulti-modal analysis\n\n\nCITE-seq\n\n\nscRNA-seq\n\n\ncode\n\n\ndata\n\n\n\n\n\n\n\n\n\nJun 20, 2024\n\n\nPatrick Cherry\n\n\n\n\n\n\n\n\n\n\n\n\nemmeans: estimated marginal means\n\n\n\n\n\n\ndata\n\n\ncode\n\n\nexperimental analysis\n\n\nDoE\n\n\nunbalanced DoE\n\n\ncausal inference\n\n\n\n\n\n\n\n\n\nMay 19, 2024\n\n\nPatrick Cherry\n\n\n\n\n\n\n\n\n\n\n\n\nDoE: Design of Experiment\n\n\n\n\n\n\nDoE\n\n\ndesign of experiment\n\n\ncode\n\n\n\n\n\n\n\n\n\nApr 5, 2024\n\n\nPatrick Cherry\n\n\n\n\n\n\n\n\n\n\n\n\nSan Francisco political support data shows true alignment\n\n\n\n\n\n\npolitics\n\n\n\n\n\n\n\n\n\nMar 3, 2024\n\n\nPatrick Cherry\n\n\n\n\n\n\n\n\n\n\n\n\nSan Francisco tree classification model\n\n\n\n\n\n\ndata\n\n\ncode\n\n\ntree models\n\n\n\n\n\n\n\n\n\nFeb 10, 2024\n\n\nPatrick Cherry\n\n\n\n\n\n\n\n\n\n\n\n\nscRNA-seq Analysis: Messy Mouse Brain\n\n\n\n\n\n\ncode\n\n\nscRNA-seq\n\n\nRNA-seq\n\n\n\n\n\n\n\n\n\nJan 22, 2024\n\n\nPatrick Cherry\n\n\n\n\n\n\n\n\n\n\n\n\nGTEX RNA-seq Liver-specific Process and TF Identification\n\n\n\n\n\n\ncode\n\n\nRNA-seq\n\n\n\nUse publicly-available GTEX bulk RNA-seq data to identify uniquely expressed genes in liver tissue, as well as pathways analysis and gene ontology enrichment analysis. Also use TFEA_ChIP to identify transcription factors enriched or depleted in the liver given the gene expression data.\n\n\n\n\n\nJan 3, 2024\n\n\nPatrick Cherry\n\n\n\n\n\n\n\n\n\n\n\n\nWhy you should elect a high-deductible health plan\n\n\n\n\n\n\nfinance\n\n\nhealthcare\n\n\n\n\n\n\n\n\n\nJan 2, 2024\n\n\nPatrick Cherry\n\n\n\n\n\n\n\n\n\n\n\n\nHow I run and deploy this Quarto blog\n\n\n\n\n\n\nnews\n\n\ncode\n\n\ncommunity\n\n\n\n\n\n\n\n\n\nDec 29, 2023\n\n\nPatrick Cherry\n\n\n\n\n\n\nNo matching items"
  }
]